CAR-T therapy

NEW YORK, June 9, 2026 Cellectis announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine...

SHANGHAI, China, June 8, 2026 OriCell Therapeutics has achieved a major regulatory and clinical milestone with the National Medical...

WATERTOWN, Massachusetts, USA & DRESDEN, Germany, June 2, 2026 AvenCell Therapeutics has announced that it will present results from...

IRVINE, California, May 29, 2026 PeproMene Bio, Inc. has announced that updated clinical data from its ongoing Phase 1...

BASEL, Switzerland, May 21, 2026 Novartis announced it will present more than 65 company-sponsored and investigator-sponsored abstracts at the...

CAMBRIDGE, Mass., May 12, 2026 Mirai Bio unveiled new preclinical data at the American Society of Gene and Cell...

WELLINGTON, New Zealand – May 6, 2026 BioOra Limited and Wellington Zhaotai Therapies Limited (WZTL) have signed a binding...

BOSTON, Massachusetts, May 2026 Kernal Biologics announced it will present new data on its mRNA 2.0 platform and T-cell-targeted...

CAMBRIDGE, Mass., April 27, 2026 Mirai Bio announced it will unveil two next-generation programs focused on targeted nucleic acid...

Houston, Texas, USA – April 23, 2026 InVita Healthcare Technologies and Gulf Coast Blood announced a major advancement in...